Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018.

Knol, Mirjam J
Ruijs, Wilhelmina Lm
Antonise-Kamp, Laura
de Melker, Hester E
van der Ende, Arie

Open PDF

Open link

Publication date

April 2018

DOI

10.2807/1560-7917.ES.2018.23.16.18-00158

Publisher

European Centre for Disease Control and Prevention (ECDC)

Journal

Eurosurveillance

Abstract

The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among < 5 year-olds and 15-24 year-olds. The case fatality rate was 12% (17/138) in 2015-2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13-14 year-olds are offered MenACWY vaccination

Extracted data

We use cookies to provide a better user experience.

Data Protection

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018.

Abstract

Extracted data

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018.

Abstract

Extracted data

Related items

Related items